standard]
MSVMRLRVQLMLILKIIFLLLSMADGETTEARDALVQFIEKLAPQRGENW
GWNRSSDPCKSGWKGVTCYSDLATIKKIVLDELNLTGMLDAASLCSTKAL
MVLSLNSNNVVGTLPDEISKCRHLTHVYLHGNKFSGSLPGSLSRLSNLKR
VDVSDNGFSGGIPDMSRISGLLTFLADNNQLSGEIPKFDFSNLEEFNVSN
NNLSGPVPDLGGRFNGTSFLGNPGLCGKPLPNACPPSPPARKKGSSKKDY
FMYSGYALIGIIIVSLVAFKLIKKGKTNSKKNVAKKGSQVTGDKESSTSS
ESKAVGGNRSEFSITSAESGRGSSSLVVLSSPMVNELKFEDLLRSPAELL
GRGRNGSLYKVTLNEGVTLAVKRIRDWYISRDDFKKRMQRIDQVKHPNVL
PVVAFYCSSQEKLLVYEFQENGSLFRLLHESKNRQSFDWGSRLALASKIS
AALAYMHEGLQADGIAHGNLKSSNILLSNEMEPLISEYGLADADNQDQSF
LAQLDSFQENNSPPGGIISSNNAFKTDTYSFGIILLELLTGNVVQNNGFD
LARWVNSAIREEWTVEVFDKALVSEGASEESMVSLLQVALKCIDISSAAR
PNMREVAGIINTIREHEEKSISSDP
|
IPR000719; Protein kinase, catalytic domain IPR001611; Leucine-rich repeat IPR002290; Serine/threonine-protein kinase domain IPR013210; Leucine-rich repeat-containing N-terminal, type 2 IPR017441; Pro |